Table 4.
Multivariate analysis results of treatment efficacy at 3-month follow-up
Variables | β Value | β Standard value | Standardized β value | t | P Value | 95.0% Confidence Interval of B | |
---|---|---|---|---|---|---|---|
Lower limit | Upper limit | ||||||
Disease duration | 0.103 | 0.038 | 0.222 | 2.697 | 0.008 | 0.027 | 0.178 |
NRS score | 0.073 | 0.118 | 0.052 | 0.623 | 0.535 | − 0.160 | 0.307 |
PSQI score | 0.114 | 0.037 | 0.265 | 3.088 | 0.002 | 0.041 | 0.187 |
Physiological function | 0.000 | 0.007 | − 0.005 | − 0.049 | 0.961 | − 0.014 | 0.014 |
Activities of daily living | 0.000 | 0.008 | − 0.002 | − 0.025 | 0.980 | − 0.016 | 0.016 |
Bodily pain | − 0.023 | 0.011 | − 0.206 | − 2.117 | 0.036 | − 0.045 | − 0.002 |
General health status | 0.011 | 0.019 | 0.061 | 0.610 | 0.543 | − 0.025 | 0.048 |
Energy levels | − 0.007 | 0.014 | − 0.058 | − 0.472 | 0.638 | − 0.035 | 0.021 |
Social functioning | 0.004 | 0.011 | 0.035 | 0.319 | 0.750 | − 0.018 | 0.025 |
Mental health | − 0.001 | 0.012 | − 0.008 | − 0.078 | 0.938 | − 0.025 | 0.023 |
PHQ9 score | 0.068 | 0.035 | 0.161 | 1.954 | 0.053 | − 0.001 | 0.137 |